In BRCA, the expression of PVRL1/CD111, PVRL2/CD112, TIGIT, and DNAM-1/CD226 in tumor tissues was significantly higher than that in normal tissues, but PVRL3/CD113 showed an opposite expression pattern. This evidence concerns the gene CD226 and neoplasm.